| Dr Brian Wilbur, MD | |
|
239 S La Cienega Blvd Ste 100, Beverly Hills, CA 90211-3355 | |
| (310) 360-0960 | |
| Not Available |
| Full Name | Dr Brian Wilbur |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 239 S La Cienega Blvd Ste 100, Beverly Hills, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376589333 | NPI | - | NPPES |
| 00A838610 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A83861 (California) | Primary |
| Entity Name | Providence Facey Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710031588 PECOS PAC ID: 3173436276 Enrollment ID: O20031105000822 |
News Archive
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
Scientists have shown in multiple contexts that DNA damage over our lifetimes is a key mechanism behind the development of cancer and other age-related diseases. Not everyone gets these diseases, because the body has multiple mechanisms for repairing the damage caused to DNA by aging, the environment and other human behaviors - but the mechanisms behind certain kinds of DNA repair have not been well-understood.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Wilbur, MD 239 S La Cienega Blvd Ste 100, Beverly Hills, CA 90211-3355 Ph: (310) 360-0960 | Dr Brian Wilbur, MD 239 S La Cienega Blvd Ste 100, Beverly Hills, CA 90211-3355 Ph: (310) 360-0960 |
News Archive
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
Scientists have shown in multiple contexts that DNA damage over our lifetimes is a key mechanism behind the development of cancer and other age-related diseases. Not everyone gets these diseases, because the body has multiple mechanisms for repairing the damage caused to DNA by aging, the environment and other human behaviors - but the mechanisms behind certain kinds of DNA repair have not been well-understood.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.
› Verified 8 days ago
Dr. Alan M Spira, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 N Robertson Blvd, Beverly Hills, CA 90211 Phone: 310-360-1331 Fax: 310-360-1333 | |
Mark Wittman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 S Spalding Dr, Ste. 301, Beverly Hills, CA 90212 Phone: 310-385-7755 | |
Eugene Jerome Carter, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1418 Lindacrest Dr, Beverly Hills, CA 90210 Phone: 310-276-5552 Fax: 310-276-5532 | |
Dr. Ruthann M Cunningham, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8767 Wilshire Blvd Fl 3, Beverly Hills, CA 90211 Phone: 310-385-6031 | |
Dr. Bruce Gary Fagel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 N Crescent Dr, Suite 360, Beverly Hills, CA 90210 Phone: 310-281-8700 Fax: 310-281-5656 | |
Zacary Trostler Schwarzkopf, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1276 Beverly Green Dr, Beverly Hills, CA 90212 Phone: 310-985-4060 |